| Literature DB >> 26229555 |
Lauren Blatchford1, Pam Morey2, Ruth McConigley3.
Abstract
BACKGROUND: There are several risk classification systems developed to facilitate diabetic foot assessments and prioritise diabetes patients for foot prevention services according to risk factors. Utilisation of both The University of Texas Diabetic Foot Risk Classification System (UTDFRCS) and The National Evidence-Based Guideline on Prevention, Identification and Management of Foot Complications in Diabetes (Part of the Guidelines on Management of Type 2 Diabetes), allows guidance for the podiatrist in terms of review timeframes for future assessments and treatment. The aim of this clinical audit was to classify Aboriginal type 2 diabetes subjects' risk status according to UTDFRCS and identify if evidence based standards are being met for podiatry services at the Albury-Wodonga Aboriginal Health Service in New South Wales, Australia.Entities:
Keywords: Australia; Indigenous health; Podiatry; Rural health; University of Texas
Year: 2015 PMID: 26229555 PMCID: PMC4520286 DOI: 10.1186/s13047-015-0089-2
Source DB: PubMed Journal: J Foot Ankle Res ISSN: 1757-1146 Impact factor: 2.303
The University of Texas Diabetic Foot Risk Classification System (adapted from [14])
|
|
|
|
|
|
|
|
|
|
| • Patient diagnosed with diabetes mellitus. | • Patient diagnosed with diabetes mellitus. | • Patient diagnosed with diabetes mellitus. | • Patient diagnosed with diabetes mellitus. |
| • Protective sensation intact (Semmes-Weinstein 10g monofilament detectable). | • Protective sensation absent (Semmes-Weinstein 10g monofilament NOT detectable). | • Protective sensation absent. | • Protective sensation. |
| • Ankle brachial index of >0.8 and toe systolic pressure of >45mmHg. | • Ankle brachial index of >0.8 and toe systolic pressure of >45mmHg. | • Ankle brachial index of >0.8 and toe systolic pressure of >45mmHg. | Ankle brachial index of >0.8 and toe systolic pressure of >45mmHg. |
| • Foot deformity may be present. | • No history of ulceration. | • No history of ulceration. | • History of neuropathic ulceration. |
| • No history of ulceration. | No history of Charcot’s joint. | • No history of Charcot’s joint. | • History of Charcot’s joint. |
| No foot deformity. | • Foot deformity present. | • Foot deformity present. | |
|
|
|
|
|
|
|
|
|
|
| • Patient diagnosed with diabetes mellitus. | • Patient diagnosed with diabetes mellitus. | • Patient diagnosed with diabetes mellitus. | • Patient diagnosed with diabetes mellitus. |
| • Protective sensation may or may not be intact. | • Protective sensation absent. | • Protective sensation may or may not be intact. | • Protective sensation may or may not be intact. |
| • Ankle brachial index of >0.8 and toe systolic pressure of >45mmHg. | • Ankle brachial index of >0.8 and toe systolic pressure of >45mmHg. | • Infected wound. | • Ankle brachial index of <0.8 and toe systolic pressure of <45mmHg. |
| • Foot deformity normally present. | • Non-infected neuropathic ulceration may be present. | • Charcot’s joint may be present. | • Ulceration may be present. |
| • Non-infected neuropathic ulceration. | • Charcot’s joint present. | ||
| • No Charcot’s joint present. |
Comparison of the University of Texas Diabetic Foot Risk Classification [9] and National Evidence Based Guidelines for risk status [7]
| University of Texas risk category | University of Texas risk definition | National Evidence Based Guidelines risk status | National Evidence Based Guidelines frequency of foot examination |
|---|---|---|---|
| 0 | No Neuropathy | “low risk”- people with no risk factors and no previous history of foot ulcer/amputation | Annually |
| 1 | Neuropathy, no deformity | “intermediate risk”- people with one risk factor (neuropathy, peripheral arterial disease or foot deformity) and no previous history of foot ulcer/amputation | Every 3 - 6 months |
| 2 | Neuropathy with deformity | “high risk” - people with two or more risk factors (neuropathy, peripheral arterial disease or foot deformity) and/or a previous history of foot ulcer/amputation | Every 3 - 6 months |
| 3 | History of pathology | ||
| 4a | Neuropathic wound | ||
| 4b | Acute Charcot’s joint | ||
| 5 | Infected diabetic foot | ||
| 6 | Ischaemic limb |
Participant data
| Variable | Total (n=70) |
|---|---|
| Gender | |
| Female (%) | 64.3 |
| Male (%) | 35.7 |
| Age (years) | 55.43 (mean) |
| Duration of diabetes (years) | 5.74 (mean) |
Number of subjects in each University of Texas Diabetic Foot Risk Classification System
| Category | Classification | Frequency | Percent |
|---|---|---|---|
| 0 | No neuropathy | 55 | 78.6 |
| 1 | Neuropathy, no deformity | 9 | 12.9 |
| 2 | Neuropathy, with deformity | 2 | 2.9 |
| 3 | History of pathology | 0 | 0 |
| 4a | Neuropathic wound | 2 | 2.9 |
| 4b | Acute Charcot’s joint | 0 | 0 |
| 5 | Infected diabetic foot | 2 | 2.9 |
| 6 | Ischaemic limb | 0 | 0 |
Fig. 1Occasions of visits to podiatry services at The Albury-Wodonga Aboriginal Health Service during a 26 month period
Participants that did not meet the evidence based requirements for review timeframes according to risk status
| Gender | Age (years) | Duration of Diabetes (years) | University of Texas Risk Status | Occasions of visits to podiatrya |
|---|---|---|---|---|
| Male | 57 | 9 | 4 | 1 |
| Male | 45 | 6 | 2 | 1 |
| Male | 68 | 4 | 1 | 1 |
| Female | 64 | 2 | 6 | 4 |
aDuring the 26 month data collection period